218 related articles for article (PubMed ID: 11433750)
1. [Screening methods in the detection of bladder cancer: comparison of nuclear matrix protein-22, bladder tumor antigen and cytological examinations].
Fukui Y; Samma S; Fujimoto K; Akiyama T; Yamaguchi A; Hirayama A
Hinyokika Kiyo; 2001 May; 47(5):311-4. PubMed ID: 11433750
[TBL] [Abstract][Full Text] [Related]
2. Comparison of nuclear matrix protein 22 and bladder tumor antigen in urine of patients with bladder cancer.
Abbate I; D'Introno A; Cardo G; Marano A; Addabbo L; Musci MD; Pagliarulo A; Correale M; Quaranta M
Anticancer Res; 1998; 18(5B):3803-5. PubMed ID: 9854500
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of BTA stat test, NMP-22, and cytology in the diagnosis of bladder cancer].
Gutiérrez Baños JL; Rebollo Rodrigo MH; Antolín Juarez F; Martín García B; Hernández Rodríguez R; Portillo Martín JA; Correas Gómez MA; del Valle Schaan JI; Roca Edreira A; de Diego Rodríguez E; Radó Velázquez MA
Arch Esp Urol; 2000; 53(1):21-7. PubMed ID: 10730421
[TBL] [Abstract][Full Text] [Related]
4. Comparisons of voided urine cytology, nuclear matrix protein-22 and bladder tumor associated antigen tests for bladder cancer of geriatric male patients in Taiwan, China.
Tsui KH; Chen SM; Wang TM; Juang HH; Chen CL; Sun GH; Chang PL
Asian J Androl; 2007 Sep; 9(5):711-5. PubMed ID: 17712491
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors.
Giannopoulos A; Manousakas T; Gounari A; Constantinides C; Choremi-Papadopoulou H; Dimopoulos C
J Urol; 2001 Aug; 166(2):470-5. PubMed ID: 11458049
[TBL] [Abstract][Full Text] [Related]
6. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
8. [Quantification of bladder tumor antigen (BTA trak) and its correlation with bladder cancer grade and stage].
Rodríguez Martínez JJ; Escaf Barmadah S; Allende MT; Raigoso P; Martín Benito JL; Pérez García FJ; Fernández Gómez JM
Arch Esp Urol; 2000; 53(1):1-6. PubMed ID: 10730418
[TBL] [Abstract][Full Text] [Related]
9. Use of urine-based markers for detection and monitoring of bladder cancer.
Pirtskalaishvili G; Getzenberg RH; Konety BR
Tech Urol; 1999 Dec; 5(4):179-84. PubMed ID: 10591254
[TBL] [Abstract][Full Text] [Related]
10. Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence.
Boman H; Hedelin H; Holmäng S
J Urol; 2002 Jan; 167(1):80-3. PubMed ID: 11743280
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of urinary nuclear matrix protein 22 as a marker for bladder cancer].
Kurokawa S; Morita T; Muraishi O; Tokue A
Hinyokika Kiyo; 2001 Apr; 47(4):247-50. PubMed ID: 11411098
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--screening for urothelial cancer in patients with microscopic hematuria. NMP Study Group].
Akaza H; Miyanaga N; Tsukamoto T; Ishikawa S; Noguchi R; Ohtani M; Kawabe K; Kubota Y; Fujita K; Obata K; Hirao Y; Kotake T; Ohmori H; Kumazawa J; Koiso K
Gan To Kagaku Ryoho; 1997 May; 24(7):837-42. PubMed ID: 9170522
[TBL] [Abstract][Full Text] [Related]
13. [Urinary tumor marker for urothelial cancer].
Ohtani M; Iwasaki A; Shiraiwa H
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1933-7. PubMed ID: 11729491
[TBL] [Abstract][Full Text] [Related]
14. Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer.
Sánchez-Carbayo M; Urrutia M; Silva JM; Romaní R; De Buitrago JM; Navajo JA
J Urol; 2001 May; 165(5):1462-7. PubMed ID: 11342897
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--NMP22 as a urinary marker for surveillance of bladder cancer. NMP22 Study Group].
Akaza H; Miyanaga N; Tsukamoto T; Ishikawa S; Noguchi R; Ohtani M; Kawabe K; Kubota Y; Fujita K; Obata K; Hirao Y; Kotake T; Ohmori H; Kumazawa J; Koiso K
Gan To Kagaku Ryoho; 1997 May; 24(7):829-36. PubMed ID: 9170521
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Bard BTA test with voided urine and bladder wash cytology in the diagnosis and management of cancer of the bladder.
Leyh H; Hall R; Mazeman E; Blumenstein BA
Urology; 1997 Jul; 50(1):49-53. PubMed ID: 9218018
[TBL] [Abstract][Full Text] [Related]
17. The role of nuclear matrix protein 22 combined with bladder tumor antigen stat test in surveillance of recurring bladder cancer.
Xu K; Tam PC; Hou S; Wang X; Bai W
Chin Med J (Engl); 2002 Nov; 115(11):1736-8. PubMed ID: 12609098
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of the bladder tumor marker "Tu-MARK-BTA"].
Yogi S; Ikeuchi T; Yoshikawa H; Hamashima T; Sasaki H; Morikawa F; Onodera Y; Matsumoto K; Kai Y
Hinyokika Kiyo; 1991 Apr; 37(4):335-9. PubMed ID: 1891992
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of nuclear matrix protein-22 as a clinical diagnostic marker for bladder cancer.
Chang YH; Wu CH; Lee YL; Huang PH; Kao YL; Shiau MY
Urology; 2004 Oct; 64(4):687-92. PubMed ID: 15491702
[TBL] [Abstract][Full Text] [Related]
20. [Determination of NMP-22 as recurrence marker in bladder cancer. Preliminary study].
Pérez García FJ; Escaf Barmadah S; Fernández Gómez JM; Rodríguez Martínez JJ; Martín Benito JL
Arch Esp Urol; 2000 May; 53(4):305-12. PubMed ID: 10900760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
